
Investments
45Portfolio Exits
7Funds
5Plymouth Growth Partners Web Traffic
Plymouth Growth Partners Rank
Latest Plymouth Growth Partners News
Mar 9, 2022
C2Dx enters the surgical suite with the first and only device of its kind for tissue dissection. News provided by Share this article Share this article KALAMAZOO, Mich., March 8, 2022 /PRNewswire/ -- C2Dx, a privately held medical device company, announced its acquisition of Hemostatix Medical Technologies LLC (Hemostatix) effective on January 1, 2022. This latest expansion aligns with C2Dx's strategy to invest in and refine the delivery of valuable niche products to propel their growth and accessibility worldwide. The acquisition of Hemostatix will mean the integration of the thermal scalpel system, employees, and customer contracts all operating under C2Dx. Product manufacturing and distribution will remain in the Memphis region of Tennessee. The Hemostatix Thermal Scalpel is the third product line for C2Dx, joining its previous acquisitions of the STIC Intra-Compartmental Pressure Monitor and T/Pump Localized Temperature Therapy system. Next generation Hemostatix scalpel handle and blade system, newly redesigned featuring blade hub to eliminate contact with blade. C2Dx makes third acquisition in three years, providing growth opportunities for the thermal scalpel. The Hemostatix Thermal Scalpel seals blood vessels as they are incised—effectively cutting and coagulating simultaneously. The surgically sharp blade enables surgeons to make precise anatomical dissection and achieve immediate hemostasis resulting in maximum visualization and superior surgical control. Featuring a 5-layer laminate composition of copper and stainless steel, with the Hemostatix Thermal Scalpel in hand, surgeons can prioritize surgical safety with no muscle excitation, reduced blood loss, and contribute to the move toward a smoke-free operating room. Founded in early 2019 by CEO Kevin McLeod and Plymouth Growth, C2Dx is led by a team of medical device industry experts who have over a century of combined experience managing growth-oriented teams across the globe. "Our leadership team has extensive experience leading all phases of medical device manufacturing. We have seen great success with both the STIC and T/Pump and are looking forward to applying our innovative strategy to this new product line," said Kevin. "The latest acquisition of Hemostatix offers an exciting chance for us to expand our product offering and grow our team as we further pursue C2Dx's mission." Brad Beale, former co-owner of Hemostatix said, "C2Dx's acquisition of Hemostatix provides a great growth opportunity for the product as well as our team. We are looking forward to providing extended service offerings to our customers as we develop the product through the combined expertise of these two companies." Brad joins C2Dx as General Manager of the Hemostatix operations. The expanded business will serve new specialties and procedures across the U.S. and internationally. About C2Dx C2Dx is a Kalamazoo, MI-based medical device company that invests in and refines the delivery of valuable, niche products to propel their growth and accessibility worldwide. Started in early 2019 and founded by industry experts, C2Dx is committed to providing leading medical products and superior customer service while continually evolving to ensure that healthcare providers have the devices and technology they need. Visit C2Dx at www.c2dx.com . About Plymouth Growth Plymouth Growth Partners invests in growth stage businesses throughout the Great Lakes region. With over 100 years of combined investing experience, Plymouth takes a flexible approach to partnering with management teams, helping to drive growth, build value and realize full potential. Plymouth focuses on B2B product and services companies that have scalable technology and proven growth. Based in Ann Arbor, Michigan, Plymouth Growth Partners has over $150 million under management and is actively investing out of its fourth fund. Visit www.plymouthgp.com . SOURCE C2Dx
Plymouth Growth Partners Investments
45 Investments
Plymouth Growth Partners has made 45 investments. Their latest investment was in Deck Commerce as part of their Series A on October 10, 2021.
Plymouth Growth Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
10/12/2021 | Series A | Deck Commerce | $7.8M | Yes | 3 | |
7/20/2021 | Series A - II | Algo | Yes | 2 | ||
2/19/2021 | Unattributed VC - II | Allied Payment Network | $2.5M | No | 1 | |
12/28/2020 | Unattributed VC | |||||
3/16/2020 | Unattributed VC - II |
Date | 10/12/2021 | 7/20/2021 | 2/19/2021 | 12/28/2020 | 3/16/2020 |
---|---|---|---|---|---|
Round | Series A | Series A - II | Unattributed VC - II | Unattributed VC | Unattributed VC - II |
Company | Deck Commerce | Algo | Allied Payment Network | ||
Amount | $7.8M | $2.5M | |||
New? | Yes | Yes | No | ||
Co-Investors | |||||
Sources | 3 | 2 | 1 |
Plymouth Growth Partners Portfolio Exits
7 Portfolio Exits
Plymouth Growth Partners has 7 portfolio exits. Their latest portfolio exit was Able on January 11, 2022.
Plymouth Growth Partners Acquisitions
1 Acquisition
Plymouth Growth Partners acquired 1 company. Their latest acquisition was KnowledgeLake on June 28, 2018.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
6/28/2018 | Debt | $1.5M | Acq - Fin | 1 |
Date | 6/28/2018 |
---|---|
Investment Stage | Debt |
Companies | |
Valuation | |
Total Funding | $1.5M |
Note | Acq - Fin |
Sources | 1 |
Plymouth Growth Partners Fund History
5 Fund Histories
Plymouth Growth Partners has 5 funds, including Plymouth Growth Partners IV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
6/30/2017 | Plymouth Growth Partners IV | Late-Stage Venture Capital | Open | $40M | 1 |
12/31/2014 | Plymouth Venture Partners I LP | ||||
7/17/2014 | Plymouth Venture Partners III | ||||
9/16/2011 | Plymouth Venture Partners II LP | ||||
Plymouth Growth Partners V |
Closing Date | 6/30/2017 | 12/31/2014 | 7/17/2014 | 9/16/2011 | |
---|---|---|---|---|---|
Fund | Plymouth Growth Partners IV | Plymouth Venture Partners I LP | Plymouth Venture Partners III | Plymouth Venture Partners II LP | Plymouth Growth Partners V |
Fund Type | Late-Stage Venture Capital | ||||
Status | Open | ||||
Amount | $40M | ||||
Sources | 1 |
Plymouth Growth Partners Team
4 Team Members
Plymouth Growth Partners has 4 team members, including current Chief Executive Officer, Mark Horne.
Name | Work History | Title | Status |
---|---|---|---|
Mark Horne | Chief Executive Officer | Current | |
Christopher Frick | Chief Financial Officer | Current | |
Robert M. Platek | Founder | Former | |
Ariel Sacerdoti | Senior Vice President | Former |
Name | Mark Horne | Christopher Frick | Robert M. Platek | Ariel Sacerdoti |
---|---|---|---|---|
Work History | ||||
Title | Chief Executive Officer | Chief Financial Officer | Founder | Senior Vice President |
Status | Current | Current | Former | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.